Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bausch + Lomb Stock Jumps Amid Reports Of A Sale
Key Takeaways Bausch + Lomb is discussing a possible sale that would separate it from its parent company, Bausch Health Cos.Bausch Health is saddled with debt of $21 billion, nearly $10 billion of which is set to mature in 2027.
Eyecare company Bausch + Lomb explores sale to end messy spin-off
Bausch Health retained an 88 per cent shareholding in the eye care subsidiary after listing the group in 2022. But it planned to offload the remainder of shares by striking a deal with its investors to exchange Bausch Health stock for Bausch + Lomb stock.
Bausch + Lomb Working With Goldman Sachs to Explore Sale: FT
Bausch + Lomb is working with advisers from Goldman Sachs to test interest from possible buyers, the Financial Times reported on Saturday.
Bausch + Lomb exploring sale options
Company operates a contact lens manufacturing facility in Waterford where approximately 1,500 people are employed.
Bausch + Lomb considers sale: FT
Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.
Bausch + Lomb reportedly exploring sale to handle Bausch Health spinoff
Bausch + Lomb (BLCO) stock will be in focus as company is exploring a sale to address concerns raised over its separation from Bausch Health (BHC). Read mroe here.
Bausch & Lomb shares jump on spin-off sale hopes
Shares in Bausch & Lomb surged on Monday amid speculation that the North American contact lens and eye care products supplier is exploring a potential sale.
Bausch + Lomb’s stock soars 18% on report company is considering selling itself
Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported.
Bausch & Lomb gains after report of PE interest in takeover
Bausch & Lomb (NYSE:BLCO) rose 1.8% in premarket trading after a report about private equity interest in a takeover of the eyecare company. Private equity firms including Blackstone (BX), Advent International,
Hosted on MSN
7d
M&A News: Bausch+Lomb (NYSE:BLCO) Potentially Exploring Sale Amid Parent Company’s Debt Struggles
Bausch+Lomb ($BLCO), a contact lens supplier, is exploring a sale to address concerns raised by its lenders like Apollo ...
7d
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a ...
4d
Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely
Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...
Plastics News
6d
Kickstart: Focusing on a possible big deal in eye care
Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...
4d
Private Equity Interest Signals Upside for Bausch + Lomb: A Buy Rating Justified
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback